MICHAEL DORFMAN: Open Payments
NPI 1629060587 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 24 payments from 9 companies in 2025. Trend: 2023 $155 · 2024 $198 · 2025 $696
Food & beverage: $585Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $205 |
| Otsuka America Pharmaceutical, Inc. | 3 | $169 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Lundbeck LLC | 3 | $49 |
| Alkermes, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII, ARISTADA, INVEGA SUSTENNA, COBENFY, SPRAVATO.
Industry payments across NC — which companies pay providers there.
